JPRN-UMIN000018936已完成未知
Effects of one of antidiabetic agents, teneligliptin, on the vascular endothelium function of ACS patients with diabetes - Effects of one of antidiabetic agents, teneligliptin, on the vascular endothelium function of ACS patients with diabetes
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •For those who fall into any of the following criteria are excluded from the study: 1. With a condition of significantly elevated blood glucose, multiple medication or insulin treatment is desirable 2. The CPK level is over 1000 after ACS onset with suspected cardiomyopathy 3. With medical history of heart disease 4. With sever ketoacidosis, diabetic coma, or precoma 5. Serious infection 6. Perioperative 7. Serious physical injury 8. Showing hypersensitiveness to any compound of teneligliptin 9. Other conditions where the patient is judged by a physician to be inappropriate to participate in the study
研究者
相似试验
已完成
4 期
The efficacy of teneligliptin in diabetic patients on hemodialysisType2 diabetic patients on hemodialysisJPRN-UMIN000010999Kawashima Hospital30
已完成
不适用
A Pilot study of anti-diabetic effects of rich Oligosaccharides fraction which is taken from Rosa arvensis in patients with type 2 diabetesIRCT2013120214333N13Barekat Pharmaceutical Company40
已完成
不适用
Effects of teneligliptin on glycemic control and bone metabolic markers in diabetic patients undergoing hemodialysisdiabetic patients undergoing hemodialysisJPRN-UMIN000010780Diamond study group10
招募中
不适用
Efficacy of the medical compound of teneligliptin 20 mg and canagliflozin 100 mg with Free Style Libretype 2 diabetes mellitusJPRN-UMIN000029015TDE Healthcare Corporation TOSAKI Clinic for Diabetes and Endocrinology40
已完成
不适用
The examination of the effects of Teneligliptin on blood glucose and albuminuria in type 2 diabetic patients with nephropathy, whose glycemic control is insufficient.Type 2 diabetic patients with nephropathyJPRN-UMIN000015922Kanazawa Medical University50